This announcement is a separate document:
共同药业：湖北共同药业股份有限公司主体及共同转债2024年度跟踪评级报告
Hubei Goto Biopharm: Hubei Jointown Pharmaceutical Group Co., Ltd.'s Main and Convertible Bonds 2024 Tracking Rating Report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.